8H-Purin-8-one, 2-amino-9-(3-deoxy-β-D-erythro-pentofuranosyl)-7,9-dihydro-7-(2-propyn-1-yl)- manufacturers
|
| | 8H-Purin-8-one, 2-amino-9-(3-deoxy-β-D-erythro-pentofuranosyl)-7,9-dihydro-7-(2-propyn-1-yl)- Basic information |
| | 8H-Purin-8-one, 2-amino-9-(3-deoxy-β-D-erythro-pentofuranosyl)-7,9-dihydro-7-(2-propyn-1-yl)- Chemical Properties |
| Boiling point | 624.9±65.0 °C(Predicted) | | density | 1.584±0.06 g/cm3(Predicted) | | pka | 13.85±0.60(Predicted) |
| | 8H-Purin-8-one, 2-amino-9-(3-deoxy-β-D-erythro-pentofuranosyl)-7,9-dihydro-7-(2-propyn-1-yl)- Usage And Synthesis |
| Uses | 2-Amino-7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-3-deoxy-ribofuranosyl)purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. 2-Amino-7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-3-deoxy-ribofuranosyl)purine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 8H-Purin-8-one, 2-amino-9-(3-deoxy-β-D-erythro-pentofuranosyl)-7,9-dihydro-7-(2-propyn-1-yl)- Preparation Products And Raw materials |
|